P.J. Álvarez‐Chinchilla

ORCID: 0000-0003-1909-3449
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous Melanoma Detection and Management
  • Contact Dermatitis and Allergies
  • Hidradenitis Suppurativa and Treatments
  • Chemotherapy-related skin toxicity
  • Colorectal and Anal Carcinomas
  • Genetic and rare skin diseases.
  • Dermatologic Treatments and Research
  • Neurofibromatosis and Schwannoma Cases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Autoimmune and Inflammatory Disorders
  • Drug-Induced Adverse Reactions
  • Nonmelanoma Skin Cancer Studies
  • Cell Image Analysis Techniques
  • Dermatological and Skeletal Disorders
  • Galectins and Cancer Biology
  • Tattoo and Body Piercing Complications
  • Mechanical Behavior of Composites
  • Protein Tyrosine Phosphatases
  • Meningioma and schwannoma management
  • Cancer and Skin Lesions
  • Occupational exposure and asthma
  • Antimicrobial agents and applications
  • Soft tissue tumor case studies
  • Phytoplasmas and Hemiptera pathogens
  • Complement system in diseases

Instituto de investigación sanitaria y biomédica de Alicante
2017-2022

Hospital General Universitario de Alicante Doctor Balmis
2017-2022

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2017-2018

Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe modalities, clinical outcomes, and management of recurrence in patients receiving Patients from our unit with maligna melanoma treated 5% combination surgery were included this study. Fourteen cases recruited (85.7% 14.3% melanoma). Eight (57.1%) received without surgery, six (42.9%) underwent narrow excision before beginning treatment. During the follow-up period,...

10.1016/j.ad.2021.07.012 article EN cc-by-nc-nd Actas Dermo-Sifiliográficas 2021-12-03

Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe modalities, clinical outcomes, and management of recurrence in patients receiving Patients from our unit with maligna melanoma treated 5% combination surgery were included this study. Fourteen cases recruited (85.7% 14.3% melanoma). Eight (57.1%) received without surgery, six (42.9%) underwent narrow excision before beginning treatment. During the follow-up period,...

10.1016/j.ad.2021.07.018 article EN cc-by-nc-nd Actas Dermo-Sifiliográficas 2022-03-04

Plexiform xanthomatous tumor was proposed as an independent neoplasm within fibrohistiocytic group a few years ago. The arguments were based on their different clinical features well own morphological and immunohistochemical findings. Nevertheless, it has not been widely studied yet, there are reports about this entity. Regarding case, we reviewed the diagnostic characteristics of underdiagnosed tumor.

10.1097/dad.0000000000001242 article EN American Journal of Dermatopathology 2018-08-01

Click here for the corresponding questions to this CME article.

10.1111/ced.13743 article EN Clinical and Experimental Dermatology 2018-09-09
Coming Soon ...